Psychoneuroimmunological Issues in Psycho-oncology

References

• Bovbjerg D. H., Redd W. H., Maier L. A., et al. Anticipatory immune suppression and nausea in women receiving cyclic chemotherapy of ovarian cancer. J Consult Clin Psychol 1990; 58: 153–157
   PubMed Web of Science ®Google Scholar
• Fawzy F. I., Kemeny M. E., Fawzy N. W., et al. A structured psychiatric intervention for cancer patients. II. Changes over time in immunological measures. Arch Gen Psychiatry 1990; 47: 729–735
   PubMed Web of Science ®Google Scholar
• Levy S. M., Herberman R. B., Maluish A. M., et al. Prognostic risk assessment in primary breast cancer by behavioral and immunological parameters. Health Psychol 1985; 4: 99–113
   PubMed Web of Science ®Google Scholar
• Levy S., Herberman R., Lippman M., et al. Correlation of stress factors with sustained depression of natural killer cell activity and predicted prognosis in patients with breast cancer. J Clin Oncol 1987; 5: 348–353
   PubMed Web of Science ®Google Scholar
• Levy S. M., Herberman R. B., Whiteside T., et al. Perceived social support and tumor estrogen/progesterone receptor status as predictors of natural killer cell activity in breast cancer patients. Psychosom Med 1990; 52: 73–85
   PubMed Web of Science ®Google Scholar
• Grossarth-Maticek R., Eysenck H. J. Length of survival and lymphocyte percentage in women with mammary cancer as a function of psychotherapy. Psychol Rep 1989; 65: 315–321
   PubMed Web of Science ®Google Scholar
• Hürny C. Psychoonkologische Forschung. Einführung in die Psycho-Onkologie, F. Meerwein. Verlag Hans Huber, Bern 1985; 13–57
   Google Scholar
• Hürny C. Psychosocial factors in cancer. Psychosocial Aspects of Oncology, J. C. Holland, R. Zittoun. Springer Verlag, Berlin 1990; 75–82, Monographs/European School of Oncology
   Google Scholar
• Holland J. C. Behavioral and psychosocial risk factors in cancer: Human studies. Handbook of Psychooncology. Psychological Care of the Patient with Cancer, J. C. Holland, J. H. Rowland. Oxford University Press, New York 1989; 705–726
   Google Scholar
• Bovbjerg D. Psychoneuroimmunology and cancer. Handbook of Psychooncology. Psychological Care of the Patient with Cancer, J. C. Holland, J. H. Rowland. Oxford University Press, New York 1989; 727–734
   Google Scholar
• Bovbjerg D. H. Psychoneuroimmunology: Implications for oncology?. Cancer 1991; 67: 828–832
   PubMed Web of Science ®Google Scholar
• Schulz K. H., Raedler A. Tumorimmunologie und Psychoimmu-nologie als Grundlagen für die Psychoonkologie. Psychother med Psychol 1986; 36: 114–129
   Google Scholar
• Psychoneuroimmunology, R. Ader. Academic Press, New York 1981
   Google Scholar
• Psychoneuroimmunology, R. Ader, D. L. Felton, N. Cohen. Academic Press, New York 1991
   Google Scholar
• Pituitary Function and Immunity, I. Berczi. CRC Press, Boca Raton, FL 1986
   Google Scholar
• Neuroimmunoendocrinology, Progress in Allergy, J. E. Blalock, K. L. Bost. Karger, Basel 1988; Vol 43
   Google Scholar
• Jankovic B. D., Markovic B. M., Spector N. H. Neuroimmune interactions: Proceedings of the second international workshop on neuroimmunomodulation. Ann NY Acad Sci 1987; 496: 1–756
   PubMedGoogle Scholar
• Biondi M., Kotzalidis G. D. Human psychoneuroimmunology today. J Clin Lab Anal 1990; 4: 22–38
   PubMed Web of Science ®Google Scholar
• Geiser D. S. Psychosocial influences on human immunity. Clin Psychol Rev 1989; 9: 689–715
   Web of Science ®Google Scholar
• Gorman J. R., Locke S. E. Neural, endocrine and immune interactions. Comprehensive Textbook of Psychiatry, 5th ed, H. I. Kaplan, B. J. Sadock. Williams & Wilkins, Baltimore 1989; 111–125
   Google Scholar
• Khansari D. N., Murgo A. J., Faith R. E. Effects of stress on the immune system. Immunol Today 1990; 11: 170–175
   PubMedGoogle Scholar
• Locke S. E., Gorman J. R. Behavior and immunity. Comprehensive Textbook of Psychiatry, 5th ed, H. I. Kaplan, B. J. Sadock. Williams & Wilkins, Baltimore 1989; 1240–1249
   Google Scholar
• Rosenberg S. A., Longo D. L., Lotze M. T. Principles and applications of biologic therapy. Cancer: Principles and Practice of Oncology, V. T. DeVita, S. Hellman, S. A. Rosenberg. Lippincott, Philadelphia 1989; 301–347
   Google Scholar
• Immunity to Cancer, A. E. Reif, M. S. Mitchel. Academic Press, Orlando, FL 1985
   Google Scholar
• Roitt I. Essential Immunology, 6th ed. Blackwell, Scientific Publications, Oxford 1988
   Google Scholar
• Fox B. Current theory of psychogenic effects on cancer incidence and prognosis. J Psychosoc Oncol 1983; 1: 17–31
   Google Scholar
• Redd W. H., Jacobsen P. B. Emotions and cancer. New perspectives on an old question. Cancer 1988; 62: 1871–1879
   PubMed Web of Science ®Google Scholar
• Cross R. J., Markesbery W. R., Brooks W. H., et al. Hypothalamic-immune interactions. I. The acute effect of anterior hypo-thalamic lesions on the immune response. Brain Res 1980; 196: 79–87
   PubMed Web of Science ®Google Scholar
• Roszman T. L., Cross R. J., Brooks W. H., . Neuroimmunomodulation: Effects of neural lesions on cellular immunity. Neural Modulation of Immunity, R. Guillermin, M. Cohn, T. Melnechuk, et al. Raven Press, New York 1985; 95–109
   Google Scholar
• Stein M., Keller S., Schleifer S. The hypothalamus and the immune response. Brain, Behavior, and Bodily Disease, H. Weiner, M. A. Hofer, A. J. Stunkard. Raven Press, New York 1981; 45–65
   Google Scholar
• Forni G., Bindoni M., Santoni A., et al. Radiofrequency destruction of the tuberoinfundibular region of hypothalamus permanently abrogates NK cell activity in mice. Nature 1983; 306: 181–184
   PubMed Web of Science ®Google Scholar
• Felten D. L., Felten S. Y., Bellinger D. L., et al. Noradrenergic sympathetic neural interactions with the immune system: Structure and function. Immunol Rev 1987; 100: 225–260
   PubMed Web of Science ®Google Scholar
• Giron L. T., Crutcher K. A., Davis J. N. Lymph nodes—A possible site for sympathetic neural regulation of immune responses. Ann Neurol 1980; 8: 520–525
   PubMed Web of Science ®Google Scholar
• Williams J. M., Felten D. L. Sympathetic innervation of murine thymus and spleen. A comparative histofluorescence study. Anal Rev 1981; 199: 531–542
   Google Scholar
• Williams J. M., Peterson R. G., Shea P. A., et al. Sympathetic innervation of murine thymus and spleen. Evidence for a functional link between the nervous and immune systems. Brain Res Bull 1981; 6: 83–84
   PubMed Web of Science ®Google Scholar
• Bulloch K., Moore R. Y. Innervation of the thymus gland by brain stem and spinal cord in mouse and rat. Am J Anat 1981; 162: 157–166
   PubMedGoogle Scholar
• Bost K. L. Hormone and neuropeptide receptors on mononuclear leukocytes. Prog Allergy 1988; 43: 68–83
   PubMedGoogle Scholar
• Calabrese J. R., King M. A., Gold P. W. Alterations in immuno-competence during stress, bereavement and depression: Focus on neuroendocrine regulations. Am J Psychiatry 1987; 144: 1123–1134
   PubMed Web of Science ®Google Scholar
• Plaut M. Lymphocyte hormone receptors. Annu Rev Immunol 1987; 5: 621–669
   PubMed Web of Science ®Google Scholar
• Blalock J. E. Production of neuroendocrine peptide hormones by the immune system. Prog Allergy 1988; 43: 1–13
   PubMedGoogle Scholar
• Besedovsky H. O., Sorkin E., Felix D., et al. Hypothalamic changes during an immune response. Eur J Immunol 1977; 7: 325–328
   PubMedGoogle Scholar
• Smith E. M. Hormonal activities of lymphokines, monokines, and other cytokines. Prog Allergy 1988; 43: 121–139
   PubMedGoogle Scholar
• Woloski B. MRNJ, Smith E. M., Meyer W. J., et al. Cortico-tropin-releasing activity of monokines. Science 1985; 230: 1035–1037
   PubMed Web of Science ®Google Scholar
• Besedovsky H., del Rey A., Sorkin E., et al. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 1986; 233: 652–654
   PubMed Web of Science ®Google Scholar
• Dinarello C. Interleukin-1. Rev Infect Dis 1984; 6: 51–95
   PubMedGoogle Scholar
• Farrar W. L., Hill J. M., Harel-Bellan A., et al. The immune logical brain. Immunol Rev 1987; 100: 361–378
   PubMed Web of Science ®Google Scholar
• Besedovsky H., del Rey A., Sorkin E. Regulatory immune-neuroendocrine feedback signals. Pituitary Function and Immunity, I. Berzci. CRC Press, Boca Raton, FL 1986; 241–249
   Google Scholar
• Bovbjerg D., Ader R. The central nervous system and learning: Feedforward regulation of immune responses. Pituitary Function and Immunity, I. Berzci. CRC Press, Boca Raton, FL 1986; 252–257
   Google Scholar
• Lennox E. S. What are tumor antigens?. Immunity to Cancer, A. E. Reif, M. S. Mitchel. Academic Press, Orlando, FL 1985; 17–27
   Google Scholar
• Hellström K. E., Hellström I. Oncogene-associated tumor antigens as targets for immunotherapy. FASEB J 1989; 3: 1715–1722
   PubMed Web of Science ®Google Scholar
• Prehn R. T., Prehn L. M. The flip side of tumor immunity. Arch Surg 1989; 124: 102–106
   PubMed Web of Science ®Google Scholar
• Heppner G. H., Miller B. E. Therapeutic implications of tumor heterogeneity. Semin Oncol 1989; 16: 91–105
   PubMed Web of Science ®Google Scholar
• Pierce G. E. Tumor immunity as related to the clinical course of cancer. The Handbook of Cancer Immunology, Vol 3–4, H. Waters. Garland, New York 1978; 71–106
   Google Scholar
• North R. J. Suppressor cells: T cells and macrophages. Immunity to Cancer, A. E. Reif, M. S. Mitchel. Academic Press, Orlando, FL 1985; 239–249
   Google Scholar
• Eura M., Maehara T., Ikawa T., et al. Suppressor cells in the effector phase of autologous cytotoxic reactions in cancer patients. Cancer Immunol Immunother 1988; 27: 147–153
   PubMed Web of Science ®Google Scholar
• Fidler I. J., Schroit A. J. Recognition and destruction of neoplastic cells by activated macrophages: Discrimination of altered self. Biochim Biophys Acta 1988; 948: 151–173
   PubMed Web of Science ®Google Scholar
• Herberman R. B. Natural killer (NK) cells: Characteristics and possible role in resistance against tumor growth. Immunity to Cancer, A. E. Reif, M. S. Mitchel. Academic Press, Orlando, FL 1985; 217–227
   Google Scholar
• Stutman O. Immunological surveillance revisited. Immunity to Cancer, A. E. Reif, M. S. Mitchel. Academic Press, Orlando, FL 1985; 323–345
   Google Scholar
• Den Otter W. Immune surveillance and natural resistance: An evaluation. Cancer Immunol Immunother 1986; 21: 85–92
   PubMed Web of Science ®Google Scholar
• Penn I. The occurrence of malignant tumors in immunosup-pressed states. Prog Allergy 1986; 37: 259–300
   PubMedGoogle Scholar
• Foon K. A. Biological response modifiers: The new immunotherapy. Cancer Res 1989; 49: 1621–1639
   PubMed Web of Science ®Google Scholar
• Classman A. B. lnterleukin-2 and lymphokine activated killer cells: Promises and cautions. Ann Clin Lab Sci 1989; 19: 51–55
   PubMed Web of Science ®Google Scholar
• Herberman R. B. lnterleukin-2 therapy of human cancer: Potential benefits versus toxicity. J Clin Oncol 1989; 7: 1–4
   PubMed Web of Science ®Google Scholar
• Belldegrun A., Kasid A., Uppenkamp M., et al. Human tumor infiltrating lymphocytes. J Immunol 1989; 142: 4520–4526
   PubMed Web of Science ®Google Scholar
• Klein H. G., Leitman S. F. Adoptive immunotnerapy in the treatment of malignant disease. Transfusion 1989; 29: 170–178
   PubMed Web of Science ®Google Scholar
• Rayner A., Grimm E. A., Lotze M. T., et al. Lymphokine-activated killer (LAK) cells. Analysis of factors relevant to immunotherapy of human cancer. Cancer 1985; 55: 1327–1233
   PubMed Web of Science ®Google Scholar
• Nathanson L. Immunology and immunotherapy of human breast cancer. Cancer Immunol Immunother 1977; 2: 209–224
   Web of Science ®Google Scholar
• Vánky F., Willems J., Kreicbergs A., et al. Correlation between lymphocyte-mediated auto-tumor reactivities and the clinical course. I. Evaluation of 46 patients with sarcoma. Cancer Immunol Immunother 1983; 16: 11–16
   PubMed Web of Science ®Google Scholar
• Vánky F., Péterffy A., Böök K., et al. Correlation between lymphocyte-mediated auto-tumor reactivities and the clinical course. II. Evaluation of 69 patients with lung carcinoma. Cancer Immunol Immunother 1983; 16: 17–22
   PubMed Web of Science ®Google Scholar
• Cannon G. B., Dean J. H., Keels M., et al. Lymphoproiiferative responses to autologous tumor extracts as prognostic indicators in patients with resected breast cancer. Int J Cancer 1981; 27: 131–138
   PubMed Web of Science ®Google Scholar
• Hacene K., Desplaces A., Brunei M., et al. Competitive prognostic value of clinicopathologic and bioimmunologic factors in primary breast cancer. Cancer 1986; 57: 245–250
   PubMed Web of Science ®Google Scholar
• Burford-Mason A., Gyte G. ML, Watkins S. M. Phytohaemagglutinin responsiveness of peripheral lymphocytes and survival in patients with primary breast cancer. Breast Cancer Res Treat 1989; 13: 243–250
   PubMed Web of Science ®Google Scholar
• Adler A., Stein J. A., Ben-Efraim S. Immunocompetence, immunosuppression, and human breast cancer. III. Prognostic significance of initial level of immunocompetence in early and advanced disease. Cancer 1980; 45: 2074–2083
   PubMed Web of Science ®Google Scholar
• Wanebo H. J., Thaler H. T., Hansen J. A., et al. Immunologic reactivity in patients with primary operable breast cancer. Cancer 1978; 41: 84–94
   PubMed Web of Science ®Google Scholar
• Krown S. E., Pinsky C. M., Wanebo H. J., et al. Immunologic reactivity and prognosis in breast cancer. Cancer 1980; 46: 1746–1752
   PubMed Web of Science ®Google Scholar
• Tartter P. I., Steinberg B., Barron D. M., et al. The prognostic significance of natural killer cytotoxicity in patients with colorectal cancer. Arch Surg 1987; 122: 1264–1268
   PubMed Web of Science ®Google Scholar
• Black M. M., Zachrau R. E., Ashikari R. H., et al. Prognostic significance of cellular immunity to autologous breast carcinoma and glycoprotein 55. Arch Surg 1989; 124: 202–206
   PubMed Web of Science ®Google Scholar
• Temoshok L., Fox B. H. Coping styles and other psychosocial factors related to medical status and to prognosis in patients with cutaneus malignant melanoma. Impact of Psychoendocrine Systems in Cancer and Immunity, B. H. Fox, B. H. New-Berry. C.J. Hogrefe, Lewiston, ME 1984; 258–287
   Google Scholar
• Greer S., Watson M. Towards a biological model of cancer: Psychological considerations. Soc Sci 1985; 20(8)773–777
   Google Scholar
• Temoshok L. Biopsychosocial studies on cutaneous malignant melanoma: Psychosocial factors associated with prognostic indicators, progression, psychophysiology and tumor-host response. Soc Sci Med 1985; 20: 833–840
   PubMed Web of Science ®Google Scholar
• Grossarth-Maticek R., Eysenck H. J., Vetter H. Personality type, smoking habit and their interaction as predictors of cancer and coronary heart disease. Personal Individ Diff 1988; 9: 479–495
   Web of Science ®Google Scholar
• Grossarth-Maticek R., Bastiaans J., Kanazir D. T. Psychosocial factors as strong predictors of mortality from cancer, ischemic heart disease and stroke: The Yugoslav prospective study. J Psy-chosom Res 1985; 29: 167–176
   PubMed Web of Science ®Google Scholar
• Eysenck H. J. Personality, stress and cancer: Predictions and prophylaxis. Br J Med Psychol 1988; 61: 57–75
   PubMed Web of Science ®Google Scholar
• Grossarth-Maticek R., Eysenck H. J., Vetter H., . The Heidelberg prospective intervention study. Primary Prevention of Cancer, W. J. Eylenbosch, A. M. Depoorter, N. van Lar-Beke, et al. Raven Press, New York 1988; 199–212
   Google Scholar
• Greer S., Morris T., Pettingale K. W. Psychological response to breast cancer. Effect on outcome. Lancet 1979; 2: 785–787
   PubMed Web of Science ®Google Scholar
• Greer S., Morris T., Pettingale K. W., et al. Psychological response to breast cancer and 15 year outcome. Lancet 1990; 335: 49–50
   PubMed Web of Science ®Google Scholar
• Hislop T. G., Waxier N. E., Coldman A. J., et al. The prognostic significance of psychosocial factors in women with breast cancer. J Chronic Dis 1987; 40: 729–735
   PubMedGoogle Scholar
• Rogentine S., Van Kammern D. P., Fox B. H., et al. Psychological factors in the prognosis of malignant melanoma: A prospective study. Psychosom Med 1979; 41: 647–655
   PubMed Web of Science ®Google Scholar
• Cassileth B. R., Lusk E. J., Miller D. S., et al. Psychological correlates of survival in advanced malignant disease. N Engl J Med 1985; 312: 1551–1555
   PubMed Web of Science ®Google Scholar
• Holland J. C., Korzun A. H., Tross S., et al. Psychosocial factors and disease-free survival in stage II breast cancer. Proc Am Soc Clin Oncol 1986; 5: 237, (abstract)
   Google Scholar
• Fox B. H. Depressive symptoms and risk of cancer. JAMA 1989; 262: 1231
   PubMed Web of Science ®Google Scholar
• Zonderman A. B., Costa P. T., McCrea R. R. Depression as a risk for cancer morbidity and mortality in a nationally representative sample. JAMA 1989; 262: 1191–1195
   PubMed Web of Science ®Google Scholar
• Kaplan G. A., Reynolds P. Depression and cancer mortality and morbidity: Prospective evidence from the Alameda County Study. J Behav Med 1988; 11: 1–13
   PubMed Web of Science ®Google Scholar
• Harm R. C., Petitti D. B. Minnesota Multiphasic Personality Inventory-rated depression and the incidence of breast cancer. Cancer 1988; 61: 845–848
   PubMed Web of Science ®Google Scholar
• Dattore P. J., Shontz F. C., Coyne L. Premorbid personality differentiation of cancer and noncancer groups: A test of the hypothesis of cancer proness. J Consult Clin Psychol 1980; 48(1)388–394
   PubMedGoogle Scholar
• Persky V. W., Kempthorne-Rawson J., Shekelle R. B. Personality and risk of cancer: 20-year follow-up of the Western Electric Study. Psychosom Med 1987; 49: 435–449
   PubMed Web of Science ®Google Scholar
• Chochinov H., Holland J. C. Bereavement: A special issue in oncology. Handbook of Psychooncology. Psychological Care of the Patient with Cancer, J. C. Holland, J. H. Rowland. Oxford University Press, New York 1989; 612–627
   Google Scholar
• Ewertz M. Bereavement and breast cancer. Br J Cancer 1986; 53: 701–703
   PubMed Web of Science ®Google Scholar
• Ramirez A. J., Craig T. KJ, Watson J. P., et al. Stress and relapse of breast cancer. Br Med J 1989; 298: 291–293
   PubMed Web of Science ®Google Scholar
• Spiegel D., Bloom J. R., Kraemer H. C., et al. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 1989; 2: 888–891
   PubMed Web of Science ®Google Scholar
• Edwards J. R., Cooper C. L., Pearl S. G., et al. The relationship between psychosocial factors and breast cancer: Some unexpected results. Behav Med 1990; 5–14, Spring
   PubMed Web of Science ®Google Scholar
• Pettingale K. W., Greer S., Tee D. EH. Serum IgA and emotional expression in breast cancer patients. J Psychosom Res 1977; 21: 395–399
   PubMed Web of Science ®Google Scholar
• Jemmott J. B., Hellman C., McClelland D. C., et al. Motivational syndromes associated with natural killer cell activity. J Behav Med 1990; 13: 53–73
   PubMed Web of Science ®Google Scholar
• Schleifer S. J., Keller S. E., Meyerson A. T., et al. Lymphocyte function in major depressive disorder. Arch Gen Psychiatry 1984; 41: 484–486
   PubMed Web of Science ®Google Scholar
• Schleifer S. J., Keller S. E., Siris S. G., et al. Depression and immunity. Lymphocyte function in ambulatory depressed patients, hospitalized schizophrenic patients and patients hospitalized for herniorrhaphy. Arch Gen Psychiatry 1985; 42: 129–133
   PubMed Web of Science ®Google Scholar
• Schleifer S. J., Keller S. E., Bond R. N., et al. Major depressive disorder and immunity. Role of age, sex, severity, and hospitalization. Arch Gen Psychiatry 1989; 46: 81–87
   PubMed Web of Science ®Google Scholar
• Irwin M., Patterson T., Smith T. L., et al. Reduction of immune function in life stress and depression. Biol Psychiatry 1990; 27: 22–30
   PubMed Web of Science ®Google Scholar
• Bartrop R. W., Luckhurst E., Lazarus L., et al. Depressed lymphocyte function after bereavement. Lancet 1977; 1: 834–836
   PubMed Web of Science ®Google Scholar
• Linn M. W., Linn B. S., Jensen J. Stressful events, dysphoric mood and immune responsiveness. Psychol Rep 1984; 54: 219–222
   PubMed Web of Science ®Google Scholar
• Schleifer S. J., Keller S. E., Camerino M., et al. Suppression of lymphocyte stimulation following bereavement. JAMA 1983; 250: 374–377
   PubMed Web of Science ®Google Scholar
• Irwin M., Daniels M., Smith T. L., et al. Impaired natural killer cell activity during bereavement. Brain Behav Immun 1987; 1: 98–104
   PubMedGoogle Scholar
• Dorian B., Garfinkel P., Brown G., et al. Aberrations in lymphocyte subpopulations and function during psychological stress. Clin Exp Immunol 1982; 50: 132–138
   PubMed Web of Science ®Google Scholar
• Halvorsen R., Vassend O. Effects of examination stress on some cellular immunity functions. J Psychosom Res 1987; 31: 693–701
   PubMed Web of Science ®Google Scholar
• Glaser R., Rice J., Speicher C. E., et al. Stress depresses interferon production by leukocytes concomitant with a decrease in natural killer cell activity. Behav Neurosci 1986; 100: 675–678
   PubMed Web of Science ®Google Scholar
• Kiecolt-Glaser J. K., Glaser R., Strain E. C., et al. Modulation of cellular immunity in medical students. J Behav Med 1986; 9: 5–21
   PubMed Web of Science ®Google Scholar
• Kiecolt-Glaser J. K., Glaser R., Williger D., et al. Psychosocial enhancement of immunocompetence in a geriatric population. Health Psychol 1985; 4: 25–41
   PubMed Web of Science ®Google Scholar
• Arentz B. B., Wasserman J., Petrini B., et al. Immune function in unemployed women. Psychosom Med 1987; 49: 3–12
   PubMed Web of Science ®Google Scholar
• Kiecolt-Glaser J. K., Ricker D., George J., et al. Urinary cortisol levels, cellular immunocompetency, and loneliness in psychiatric inpatients. Psychosom Med 1984; 46: 15–23
   PubMed Web of Science ®Google Scholar
• Kiecolt-Glaser J. K., Garner W., Speicher S., et al. Psychosocial modifiers of immunocompetence in medical students. Psychosom Med 1984; 46: 7–14
   PubMed Web of Science ®Google Scholar
• Kennedy S., Kiecolt-Glaser J. K., Glaser R. Immunological consequences of acute and chronic stressors: Mediating role of interpersonal relationships. Br J Med Psychol 1988; 61: 77–85
   PubMed Web of Science ®Google Scholar
• Kiecolt-Glaser J. K., Fisher L. D., Ogrocki P., et al. Marital quality, marital disruption, and immune function. Psychosom Med 1987; 49: 13–34
   PubMed Web of Science ®Google Scholar
• Knapp P. H., Giorgi R., Levy E., et al. Short term immunologic effects of induced emotion. Psychosom Med 1990; 52: 246, (abstract)
   Web of Science ®Google Scholar
• Futterman A. D., Kemeny M. E., Fahey J. L. Short term immune changes associated with experimentally-induced positive and negative mood states. First International Congress of the International Society for Neuroimmunomodulation, FlorenceItaly, May, 23–261990, (abstract)
   Google Scholar
• Landmann R. M., Müller F. B., Perini C., et al. Changes of immunoregulatory cells induced by psychological and physical stress: Relationship to plasma catecholamines. Clin Exp Immunol 1984; 58: 127–135
   PubMed Web of Science ®Google Scholar
• Jamner L. D., Schwartz G. E., Leigh H. The relationship between repressive and defensive coping styles and monocyte, eosinophile, and serum glucose levels: Support for the opioid peptide hypothesis of repression. Psychosom Med 1988; 50: 567–575
   PubMed Web of Science ®Google Scholar
• Glaser R., Rice J., Sheridan J., et al. Stress-related immune suppression: Health implications. Brain Behav Immunol 1987; 1: 7–20
   PubMedGoogle Scholar
• Glaser R., Kennedy S., Lafuse W. P., et al. Psychological stress-induced modulation of interleukin-2 receptor gene expression and interleukin-2 production in peripheral blood leukocytes. Arch Gen Psychiatry 1990; 47: 707–712
   PubMed Web of Science ®Google Scholar
• Zielinski C. C., Tichatschek E., Müller C., et al. Association of increased lytic effector cell function with high estrogen receptor levels in tumor-bearing patients with breast cancer. Cancer 1989; 63: 1985–1989
   PubMed Web of Science ®Google Scholar
• Razavi D., Farvacques C., Delvaux N., et al. Psychosocial correlates of oestrogen and progesterone receptors in breast cancer. Lancet 1990; 335: 931–933
   PubMed Web of Science ®Google Scholar
• Pattison C. W., Woods K. L., Morrison J. M. Lymphocytopenia as an independent predictor of early recurrence in breast cancer. Br J Cancer 1987; 55: 75–76
   PubMed Web of Science ®Google Scholar
• Papatestas A. E., Lesnick G. J., Genkins G., et al. The prognostic significance of peripheral lymphocyte counts in patients with breast carcinoma. Cancer 1976; 37: 164–168
   PubMed Web of Science ®Google Scholar
• Ader R., Cohen N. CNS-immune system interactions: Conditioning phenomena. Behav Brain Sci 1985; 8: 379–395
   Web of Science ®Google Scholar
• Ader R., Cohen N. The influence of conditioning on immune responses. Psychoneuroimmunology, R. Ader, D. L. Felton, N. Cohen. Academic Press, New York 1991
   Google Scholar
• Ader R., Cohen N. Behaviorally conditioned immunosuppression. Psychosom Med 1975; 37: 333–340
   PubMed Web of Science ®Google Scholar
• Lysle D. T., Cunnick J. E., Fowler H., et al. Pavlovian conditioning of shock-induced suppression of lymphocyte reactivity: Acquisition, extinction, and preexposure effects. Life Sci 1988; 42: 2185–2194
   PubMed Web of Science ®Google Scholar
• Ader R., Cohen N. Behaviorally conditioned immunosuppression and murine systemic lupus erythematosus. Science 1982; 214: 1534–1536
   Google Scholar
• Groczynski R. M., Kennedy M., Ciampi A. Cimetidine reverses tumor growth enhancement of plasmocytoma tumors in mice demonstrating conditioned immune suppression. J Immunol 1985; 134: 421–426
   Google Scholar
• Bovbjerg D., Ader R., Cohen N. Behaviorally conditioned suppression of a graft-vs-host response. Proc Nat Acad Sci USA 1982; 79: 583–585
   PubMed Web of Science ®Google Scholar
• Kiecolt-Glaser J. K., Glaser R. Methodological issues in behavioral immunology research with humans. Brain Behav Immun 1988; 2: 67–78
   PubMedGoogle Scholar
• Sabbioni M., Hürny C. Psychoneuroimmunological studies. Psychosocial Aspects of Oncology, J. C. Holland, R. Zittoun. Springer-Verlag, Berlin 1990; 127–132, Monographs/European School of Oncology
   Google Scholar
• Pettingale K. W. Towards a psychobiological model of cancer: Biological consideration. Soc Sci Med 1985; 20: 779–787
   PubMed Web of Science ®Google Scholar
• Kiecolt-Glaser J. K., Stephens R. E., Lipetz P. D., et al. Distress and DNA repair in human lymphocytes. J Behav Med 1985; 8: 311–320
   PubMed Web of Science ®Google Scholar
• Ironson G., LaPierre A., Antoni M., et al. Changes in immune and psychological measures as a function of anticipation and reaction to news of HIV-1 antibody status. Psychosom Med 1990; 52: 247–270
   PubMed Web of Science ®Google Scholar